Searched for
DIAGNOSTICS IN HEALTHCARE
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
Paediatric healthcare startup Hoola Health raises $5 million from Peak XV’s Surge, othersThe Bengaluru-headquartered startup, founded in 2024 by Deeksha Senguttuvan, offers paediatric consultations, vaccinations, diagnostics, de...
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
Which AI products are actually delivering results? The innovations defining enterprise AI in 2026The AI era has moved from potential to proof. In 2026, the products that matter are not the most complex; they are the ones delivering meas...
Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...
PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...
Should you buy OPD cover in health insurance? Over 40% of healthcare costs are paid out-of-pocket in IndiaOPD cover in health insurance addresses out-of-pocket expenses for doctor visits, diagnostics, and medicines without hospitalization. While...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
Buy financials, healthcare, and manufactured exports; Pramod Gubbi on investing in a tricky marketIndia's Q4 earnings show recovery signs, with Nifty 100 profits up 13%. However, macro headwinds like rising crude oil prices and a depreci...
Ayushman Bharat Digital Mission crosses landmark milestone of 90 crore ABHA accountsIn a significant achievement towards building a digitally empowered healthcare ecosystem, the Ayushman Bharat Digital Mission (ABDM), imple...
From clinics to clicks: Internet emerges as ‘second doctor’ for confused patientsPatients in Delhi-NCR are confused after doctor visits. Many do not understand their health conditions or treatment plans. Nearly eight out...
Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
AI for Bharat: How inclusive innovation is redefining India's tech futureIndia's AI opportunity lies beyond boardrooms in villages, regional languages, and underserved communities. The AI for Bharat & Inclusive I...
Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARRThe company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...
"India has scientific capability to emerge as global leader in health technologies": NITI Aayog's Gobardhan DasIndia's largest biomedical event, 'Medical Innovations Patent Mitra: Innovators-to-Industry Connect', successfully took place in New Delhi....
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...